APA (7th ed.) Citation

Franciosi, A. N., Hobbs, B. D., McElvaney, O. J., Molloy, K., Hersh, C., Clarke, L., . . . McElvaney, N. G. (2020). Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency. American journal of respiratory and critical care medicine, 202(1), 73-82. https://doi.org/10.1164/rccm.202002-0262OC

Chicago Style (17th ed.) Citation

Franciosi, Alessandro N., et al. "Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency." American Journal of Respiratory and Critical Care Medicine 202, no. 1 (2020): 73-82. https://doi.org/10.1164/rccm.202002-0262OC.

MLA (9th ed.) Citation

Franciosi, Alessandro N., et al. "Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency." American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 1, 2020, pp. 73-82, https://doi.org/10.1164/rccm.202002-0262OC.